Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Seeking Alpha
Biogen
EMA
Europe
MS
multiple sclerosis
Tecfidera
generics
Flag link:
Jazz loses appeal, will have patent delisted from the Orange Book
Jazz loses appeal, will have patent delisted from the Orange Book
Endpoints
Jazz Pharma
Orange Book
narcolepsy
generics
legal
Flag link:
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Endpoints
generics
Dr Reddy's
Mayne Pharma
Flag link:
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Amarin
Hikma
legal
antitrust
generics
Vascepa
Flag link:
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
Endpoints
Sun Pharma
generics
product recalls
Diltiazem
hypertension
Flag link:
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Flag link:
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Novartis
Supreme Court
Gilenya
patents
generics
multiple sclerosis
MS
Flag link:
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug
Jazz sues generics makers for infringement on cannabis-derived epilepsy drug
Fierce Pharma
Jazz Pharma
legal
cannabindoids
Epidiolex
generics
patents
Flag link:
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Novartis
generics
antitrust
legal
Exforge
hypertension
Flag link:
Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing
Forbes
Mark Cuban
generics
drug pricing
Mark Cuban Cost Plus Drugs
Flag link:
Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors
Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors
Endpoints
Lupin
generics
regulatory
FDA
inspections
Flag link:
FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial
FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial
Endpoints
Sarepta Therapeutics
generics
Duchenne Muscular Dystrophy
FDA
eteplirsen
Flag link:
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
Fierce Pharma
Bristol Myers Squibb
Celgene
Revlimid
patents
generics
Flag link:
FDA sees room for growth for complex generics
FDA sees room for growth for complex generics
RAPS.org
generics
complex generics
regulagtory
Flag link:
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
Endpoints
AbbVie
Orilissa
generics
Sandoz
Teva Pharmaceuticals
endometriosis
Flag link:
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Flag link:
Takeda sues Apotex over prospective generic versions of its top leukemia drug
Takeda sues Apotex over prospective generic versions of its top leukemia drug
Endpoints
Takeda
Iclusig
generics
Apotex
Flag link:
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Flag link:
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Flag link:
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »